FSD Pharma Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer
Management addition comes as FSD accelerates specialty cannabinoid pharmaceutical global expansion strategy
TORONTO, Nov. 26, 2018 - FSD Pharma Inc. ("FSD Pharma" or "FSD") (CSE: H ...
↧